Lincoln Pharmaceuticals (NSE:LINCOLN) Short Interest


NSE:LINCOLN Lincoln Pharmaceuticals Ltd NSE:LINCOLN
76 GF Score
Price ₹631.55
GF Value ₹701.36
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lincoln Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:LINCOLN vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lincoln Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lincoln Pharmaceuticals Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lincoln Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Lincoln Pharmaceuticals's Short Interest falls into.


NSE:LINCOLN
76GF Score
Lincoln Pharmaceuticals Ltd NSE:LINCOLN
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lincoln Pharmaceuticals (NSE:LINCOLN) Overvalued in 2026?

Based on GuruFocus' analysis, Lincoln Pharmaceuticals stock appears to be undervalued. The current stock price of ₹631.55 is trading 10% below its estimated GF Value™ of ₹701.36. GuruFocus considers Lincoln Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NSE:LINCOLN:

  • Short Interest:
  • GF Value™: ₹701.36 vs. price of ₹631.55 (10% below fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the NSE:LINCOLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lincoln Pharmaceuticals Business Description

Other Exchanges 531633:India
Address Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
76GF Score

Get the complete analysis for NSE:LINCOLN

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹631.55
Price
₹701.36
GF Value